Dose-Effect Relationship of Kidney Function After SABR for Primary Renal Cell Carcinoma: TROG 15.03 FASTRACK II-Reference-Cited by-同舟云学术

Dose-Effect Relationship of Kidney Function After SABR for Primary Renal Cell Carcinoma: TROG 15.03 FASTRACK II

Published:2024-04 Issue: Volume: Page:
ISSN:0360-3016
Container-title:International Journal of Radiation Oncology*Biology*Physics
language:en
Short-container-title:International Journal of Radiation Oncology*Biology*Physics

Author:

Gaudreault Mathieu,Hardcastle Nicholas,Jackson Price,McIntosh Lachlan,Higgs Braden,Pryor David,Sidhom Mark,Dykyj Rachael,Moore Alisha,Kron Tomas,Siva Shankar

Funder

Varian Medical Systems Inc

Peter MacCallum Cancer Foundation Ltd

Cancer Council Victoria

University of Wollongong

Publisher

Elsevier BV

Reference30 articles.

1. Is there a role for stereotactic radiotherapy in the treatment of renal cell carcinoma?;Rühle;Clin Transl Radiat Oncol,2019

2. Radiotherapy and renal cell carcinoma: A continuing saga;Spyropoulou;In Vivo,2021

3. Stereotactic ablative body radiation therapy for primary kidney cancer: A 3-dimensional conformal technique associated with low rates of early toxicity;Pham;Int J Radiat Oncol Biol Phys,2014

4. Renal cancer is not radioresistant: Slowly but continuing shrinkage of the tumor after stereotactic body radiation therapy;Funayama;Technol Cancer Res Treat,2019

5. The emerging role of stereotactic ablative radiotherapy for primary renal cell carcinoma: A systematic review and meta-analysis;Correa;Eur Urol Focus,2019

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Landscape of Stereotactic Ablative Radiotherapy (SABR) for Renal Cell Cancer (RCC);Cancers;2024-07-27

2. Functional Outcomes of Stereotactic Ablative Radiotherapy: There Is Room for Improvement;European Urology Oncology;2024-07